Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Johnson & Johnson (JNJ)  
$149.12 1.21 (0.82%) as of 4:30 Mon 4/22


Download
   
Exchange: New York Stock Exchange
Security Type: Common
Shares Out: 2,630,000,000
Market Cap: 392.19(B)
Last Volume: 10,114,860 Avg Vol: 8,309,526
52 Week Range: $144.45 - $174.48
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Major

Member Indexes:

    S&P COMPOSITE 1500     DOW JONES COMPOSITE
    DOW JONES INDUSTRIAL AVERAGE     NYSE COMPOSITE
    S&P 100     S&P 500
    MAJOR MARKET

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  21
Guru Rank Value     : 20.3
Guru Occurances    : 6

 

            6 Months   1 Year   2 Year  
 
Company Profile   Johnson & Johnson is a holding company. Through its subsidiaries, Co. is engaged in the research and development, manufacture and sale of products in the health care field. Co. has three business segments: Consumer Health, which includes products focused on personal healthcare used in the skin health/beauty, over-the-counter medicines, baby care, oral care, women's health and wound care markets; Pharmaceutical, which is focused on six therapeutic areas: Immunology, Infectious Diseases, Neuroscience, Oncology, Cardiovascular and Metabolism and Pulmonary Hypertension; and Medical Devices, which includes products used in the Interventional Solutions, Orthopaedics, Surgery, and Vision fields.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 68,288 68,288 115,451 551,869
Total Sell Value $10,723,734 $10,723,734 $18,652,688 $94,297,224
Total People Sold 2 2 5 10
Total Sell Transactions 2 2 5 25
End Date 2024-01-21 2023-10-20 2023-04-21 2022-04-21

   
Records found: 1524
  Page 1 of 61  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Broadhurst Vanessa EVP, Global Corp Affairs   •       •      –    2024-03-13 4 S $162.16 $1,441,765 D/D (8,891) 15,043 8%     
   Schmid Timothy EVP, WW Chair, MedTech   •       •      –    2024-02-13 4 D $157.85 $39,463 D/D (250) 13,040     -
   Schmid Timothy EVP, WW Chair, MedTech   •       •      –    2024-02-13 4 OE $0.00 $0 D/D 499 13,290     -
   Swanson James D. EVP, CIO   •       •      –    2024-02-13 4 D $157.85 $30,781 D/D (195) 14,570     -
   Swanson James D. EVP, CIO   •       •      –    2024-02-13 4 OE $0.00 $0 D/D 447 14,765     -
   Hait William See Remarks   •       •      –    2024-02-13 4 D $157.85 $67,402 D/D (427) 38,647     -
   Hait William See Remarks   •       •      –    2024-02-13 4 OE $0.00 $0 D/D 834 39,074     -
   Wolk Joseph J Exec VP, CFO   •       •      –    2024-02-13 4 D $157.85 $122,018 D/D (773) 68,890     -
   Wolk Joseph J Exec VP, CFO   •       •      –    2024-02-13 4 OE $0.00 $0 D/D 1,780 69,663     -
   Broadhurst Vanessa EVP, Global Corp Affairs   •       •      –    2024-02-13 4 D $157.85 $32,991 D/D (209) 23,934     -
   Broadhurst Vanessa EVP, Global Corp Affairs   •       •      –    2024-02-13 4 OE $0.00 $0 D/D 408 24,143     -
   Wengel Kathryn E EVP, Chief TO and Risk Officer   •       •      –    2024-02-13 4 D $157.85 $52,564 D/D (333) 82,266     -
   Wengel Kathryn E EVP, Chief TO and Risk Officer   •       •      –    2024-02-13 4 OE $0.00 $0 D/D 651 82,599     -
   Taubert Jennifer L EVP, WWC. Innovative Medicine   •       •      –    2024-02-13 4 D $157.85 $105,128 D/D (666) 154,851     -
   Taubert Jennifer L EVP, WWC. Innovative Medicine   •       •      –    2024-02-13 4 OE $0.00 $0 D/D 1,302 155,517     -
   Duato Joaquin CEO and Chairman of the Board   •       •      –    2024-02-13 4 D $157.85 $237,880 D/D (1,507) 363,302     -
   Duato Joaquin CEO and Chairman of the Board   •       •      –    2024-02-13 4 OE $0.00 $0 D/D 3,470 364,809     -
   Fasolo Peter Exec VP, Chief HR Officer   •       •      –    2024-02-13 4 D $157.85 $74,821 D/D (474) 112,076     -
   Fasolo Peter Exec VP, Chief HR Officer   •       •      –    2024-02-13 4 OE $0.00 $0 D/D 925 112,550     -
   Forminard Elizabeth Executive VP, General Counsel   •       •      –    2024-02-13 4 D $157.85 $37,253 D/D (236) 8,340     -
   Forminard Elizabeth Executive VP, General Counsel   •       •      –    2024-02-13 4 OE $0.00 $0 D/D 651 8,576     -
   Decker Robert J VP Corporate Controller   •       •      –    2024-02-13 4 D $157.85 $13,575 D/D (86) 18,973     -
   Decker Robert J VP Corporate Controller   •       •      –    2024-02-13 4 OE $0.00 $0 D/D 313 19,059     -
   Schmid Timothy EVP, WW Chair, MedTech   •       •      –    2024-02-12 4 D $157.40 $454,414 D/D (2,887) 12,791     -
   Schmid Timothy EVP, WW Chair, MedTech   •       •      –    2024-02-12 4 OE $0.00 $0 D/D 5,736 15,678     -

  1524 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 61
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed